Loading...
This week, NEJM Journal Watch and Physician's First Watch have brought you coverage of study findings presented at the American Heart Association's annual Scientific Sessions, held in Chicago this year. Here is a compilation of our coverage, listed by date and title of meeting presentations, with the articles' first authors in parentheses.
(Your NEJM Journal Watch subscription is required, except where noted.)
Monday, November 12, 2018
Department of Health and Human Services' Physical Activity Guidelines for Americans (Piercy KL et al.)
Physician's First Watch coverage (free)
Sunday, November 11, 2018
Angiotensin–Neprilysin Inhibition in Acute Decompensated Heart Failure: PIONEER-HF (Velazquez EJ et al.)
Endoscopic Vein Harvest for Coronary Bypass Surgery in a Randomized Multicenter Trial with Long-Term Follow-up (Zenati MA et al.)
Withdrawal of Pharmacological Heart Failure Therapy in Recovered Dilated Cardiomyopathy — A Randomised Controlled Trial: TRED-HF (Halliday BP et al.)
Saturday, November 10, 2018
2018 AHA/ACC Cholesterol Clinical Practice Guidelines (Grundy SM et al.)
Physician's First Watch coverage (free)
The VITamin D and OmegA-3 TriaL: Principal Results for Vitamin D and Omega-3 Fatty Acid Supplementation in the Primary Prevention of Cardiovascular Disease and Cancer (Manson JE et al.)
NEJM Journal Watch coverage (vitamin D)
NEJM Journal Watch coverage (omega-3)
Physician's First Watch coverage (free)
The Primary Results of the REDUCE-IT Trial (Bhatt DL et al.)
The Cardiovascular Inflammation Reduction Trial (CIRT): Low Dose Methotrexate for the Prevention of Atherosclerotic Event (Ridker PM et al.)
The Dapagliflozin Effect on Cardiovascular Events (DECLARE)-TIMI 58 Trial (Wiviott SD et al. and Zelniker TA et al.)
Phase 2 Trial of Electrophysiology-Guided Noninvasive Cardiac Radioablation for Ventricular Tachycardia: ENCORE-VT (Robinson CG et al.)